InvestSMART

Oneview Healthcare Plc (ASX:ONE)

ALERT: Price-sensitive ASX Announcement for ONE
Current share price for ONE : $0.155 -0.17 (-52.31%)+
Announcement
Release
12 Feb 2026 8:13AM
Price at Release
$0.325
Full Release
download
Summary
The Oneview Healthcare Plc Appendix 4E Preliminary Final Report for the financial year ending 31 December 2025 outlines a 21% increase in total revenue to €12.001 million compared to 2024, primarily driven by recurring software usage revenue and hardware sales. Despite revenue growth, the company reported a loss after tax of €12.588 million, an increase from the previous year's loss of €10.836 million. The report highlights increased expenses from operational activities and non-cash items such as share-based payments, contributing to the financial loss. The company did not declare any dividends for the year and saw a net decrease in cash held by €8.78 million, with cash and equivalents totaling €4.602 million at year-end. Key activities included the issuance and cancellation of shares, investment in property and intangible assets, and the receipt of R&D tax credits. The report remains unaudited but is under review.
Key Points
  • Total revenue increased by 21% to €12.001 million.
  • Recurring revenue from software usage and content grew by 7%.
  • The company reported a loss after tax of €12.588 million.
  • Net cash used in operating activities was €8.367 million.
  • Cash and cash equivalents decreased to €4.602 million.
  • There were no dividends declared for the year.
  • The report is unaudited but under review.
  • Share based payments and foreign exchange impacts were significant.
  • The report includes financial details for both 2024 and 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.